nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—SLC22A1—prostate cancer	0.142	0.37	CbGaD
Ranitidine—CYP3A5—prostate cancer	0.115	0.298	CbGaD
Ranitidine—CYP2C19—prostate cancer	0.0781	0.203	CbGaD
Ranitidine—CYP3A4—prostate cancer	0.0497	0.129	CbGaD
Ranitidine—CYP3A5—Flutamide—prostate cancer	0.0196	0.0474	CbGbCtD
Ranitidine—SLC22A8—Conjugated Estrogens—prostate cancer	0.0195	0.047	CbGbCtD
Ranitidine—CYP2C19—Nilutamide—prostate cancer	0.0191	0.0461	CbGbCtD
Ranitidine—CYP2C19—Bicalutamide—prostate cancer	0.0191	0.0461	CbGbCtD
Ranitidine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0176	0.0424	CbGbCtD
Ranitidine—SLC22A1—Estradiol—prostate cancer	0.0173	0.0418	CbGbCtD
Ranitidine—SLC22A8—Estradiol—prostate cancer	0.0171	0.0412	CbGbCtD
Ranitidine—CYP2C19—Flutamide—prostate cancer	0.0158	0.0382	CbGbCtD
Ranitidine—CYP1A2—Flutamide—prostate cancer	0.0146	0.0353	CbGbCtD
Ranitidine—CYP2D6—Bicalutamide—prostate cancer	0.0145	0.0351	CbGbCtD
Ranitidine—CYP3A5—Cabazitaxel—prostate cancer	0.0145	0.035	CbGbCtD
Ranitidine—ABCB1—Estramustine—prostate cancer	0.0143	0.0346	CbGbCtD
Ranitidine—CYP3A5—Estrone—prostate cancer	0.0142	0.0342	CbGbCtD
Ranitidine—CYP2D6—Abiraterone—prostate cancer	0.012	0.029	CbGbCtD
Ranitidine—CYP1A2—Estrone—prostate cancer	0.0106	0.0255	CbGbCtD
Ranitidine—ABCB1—Cabazitaxel—prostate cancer	0.00946	0.0228	CbGbCtD
Ranitidine—CYP3A4—Bicalutamide—prostate cancer	0.00925	0.0223	CbGbCtD
Ranitidine—ABCB1—Estrone—prostate cancer	0.00925	0.0223	CbGbCtD
Ranitidine—CYP3A4—Estramustine—prostate cancer	0.0086	0.0207	CbGbCtD
Ranitidine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00824	0.0199	CbGbCtD
Ranitidine—CYP3A5—Estradiol—prostate cancer	0.00816	0.0197	CbGbCtD
Ranitidine—CYP3A4—Flutamide—prostate cancer	0.00766	0.0185	CbGbCtD
Ranitidine—CYP3A4—Abiraterone—prostate cancer	0.00766	0.0185	CbGbCtD
Ranitidine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00692	0.0167	CbGbCtD
Ranitidine—CYP2C19—Estradiol—prostate cancer	0.00658	0.0159	CbGbCtD
Ranitidine—CYP1A2—Estradiol—prostate cancer	0.00607	0.0146	CbGbCtD
Ranitidine—ABCB1—Conjugated Estrogens—prostate cancer	0.00605	0.0146	CbGbCtD
Ranitidine—CYP3A4—Cabazitaxel—prostate cancer	0.00567	0.0137	CbGbCtD
Ranitidine—CYP2C19—Prednisone—prostate cancer	0.00566	0.0136	CbGbCtD
Ranitidine—CYP3A4—Estrone—prostate cancer	0.00554	0.0134	CbGbCtD
Ranitidine—ABCB1—Mitoxantrone—prostate cancer	0.0055	0.0133	CbGbCtD
Ranitidine—CYP3A5—Etoposide—prostate cancer	0.00533	0.0128	CbGbCtD
Ranitidine—ABCB1—Estradiol—prostate cancer	0.00531	0.0128	CbGbCtD
Ranitidine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00494	0.0119	CbGbCtD
Ranitidine—CYP3A5—Docetaxel—prostate cancer	0.00487	0.0118	CbGbCtD
Ranitidine—ABCB1—Prednisone—prostate cancer	0.00457	0.011	CbGbCtD
Ranitidine—CYP1A2—Etoposide—prostate cancer	0.00397	0.00956	CbGbCtD
Ranitidine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00362	0.00874	CbGbCtD
Ranitidine—ABCB1—Etoposide—prostate cancer	0.00347	0.00836	CbGbCtD
Ranitidine—CYP3A4—Mitoxantrone—prostate cancer	0.00329	0.00794	CbGbCtD
Ranitidine—CYP3A4—Estradiol—prostate cancer	0.00318	0.00767	CbGbCtD
Ranitidine—ABCB1—Docetaxel—prostate cancer	0.00317	0.00765	CbGbCtD
Ranitidine—CYP3A4—Prednisone—prostate cancer	0.00274	0.0066	CbGbCtD
Ranitidine—ABCB1—Doxorubicin—prostate cancer	0.00236	0.0057	CbGbCtD
Ranitidine—CYP2D6—Doxorubicin—prostate cancer	0.00223	0.00537	CbGbCtD
Ranitidine—CYP3A4—Etoposide—prostate cancer	0.00208	0.00501	CbGbCtD
Ranitidine—SLC22A8—urine—prostate cancer	0.00192	0.164	CbGeAlD
Ranitidine—CYP3A4—Docetaxel—prostate cancer	0.0019	0.00458	CbGbCtD
Ranitidine—CYP2C19—urine—prostate cancer	0.00161	0.137	CbGeAlD
Ranitidine—CYP3A4—Doxorubicin—prostate cancer	0.00142	0.00342	CbGbCtD
Ranitidine—CYP1A2—urine—prostate cancer	0.00131	0.112	CbGeAlD
Ranitidine—CYP3A4—urine—prostate cancer	0.000952	0.0811	CbGeAlD
Ranitidine—CYP2D6—urine—prostate cancer	0.000936	0.0798	CbGeAlD
Ranitidine—SLC22A8—prostate gland—prostate cancer	0.000689	0.0588	CbGeAlD
Ranitidine—SLC22A1—renal system—prostate cancer	0.000511	0.0436	CbGeAlD
Ranitidine—SLC22A8—renal system—prostate cancer	0.00047	0.0401	CbGeAlD
Ranitidine—CYP3A5—prostate gland—prostate cancer	0.000455	0.0388	CbGeAlD
Ranitidine—HRH2—lymph node—prostate cancer	0.000372	0.0317	CbGeAlD
Ranitidine—CYP1A2—renal system—prostate cancer	0.000322	0.0274	CbGeAlD
Ranitidine—CYP3A5—renal system—prostate cancer	0.00031	0.0265	CbGeAlD
Ranitidine—ABCB1—prostate gland—prostate cancer	0.000242	0.0206	CbGeAlD
Ranitidine—CYP3A4—renal system—prostate cancer	0.000233	0.0199	CbGeAlD
Ranitidine—CYP2D6—renal system—prostate cancer	0.000229	0.0195	CbGeAlD
Ranitidine—ABCB1—seminal vesicle—prostate cancer	0.000205	0.0174	CbGeAlD
Ranitidine—ABCB1—epithelium—prostate cancer	0.000178	0.0151	CbGeAlD
Ranitidine—ABCB1—renal system—prostate cancer	0.000165	0.0141	CbGeAlD
Ranitidine—ABCB1—urethra—prostate cancer	0.000162	0.0138	CbGeAlD
Ranitidine—CYP2D6—testis—prostate cancer	0.000148	0.0126	CbGeAlD
Ranitidine—ABCB1—bone marrow—prostate cancer	0.000125	0.0106	CbGeAlD
Ranitidine—ABCB1—testis—prostate cancer	0.000107	0.00908	CbGeAlD
Ranitidine—ABCB1—lymph node—prostate cancer	7.72e-05	0.00658	CbGeAlD
Ranitidine—Anaphylactic shock—Etoposide—prostate cancer	6.49e-05	0.00056	CcSEcCtD
Ranitidine—Feeling abnormal—Mitoxantrone—prostate cancer	6.43e-05	0.000555	CcSEcCtD
Ranitidine—Blood creatinine increased—Doxorubicin—prostate cancer	6.42e-05	0.000554	CcSEcCtD
Ranitidine—Erythema—Capecitabine—prostate cancer	6.4e-05	0.000552	CcSEcCtD
Ranitidine—Dysphagia—Epirubicin—prostate cancer	6.4e-05	0.000552	CcSEcCtD
Ranitidine—Thrombocytopenia—Etoposide—prostate cancer	6.36e-05	0.000548	CcSEcCtD
Ranitidine—Tachycardia—Etoposide—prostate cancer	6.34e-05	0.000547	CcSEcCtD
Ranitidine—Eosinophilia—Epirubicin—prostate cancer	6.34e-05	0.000547	CcSEcCtD
Ranitidine—Nausea—Goserelin—prostate cancer	6.28e-05	0.000541	CcSEcCtD
Ranitidine—Hyperhidrosis—Etoposide—prostate cancer	6.28e-05	0.000541	CcSEcCtD
Ranitidine—Pancreatitis—Epirubicin—prostate cancer	6.27e-05	0.000541	CcSEcCtD
Ranitidine—Abdominal pain upper—Doxorubicin—prostate cancer	6.26e-05	0.00054	CcSEcCtD
Ranitidine—Angina pectoris—Epirubicin—prostate cancer	6.23e-05	0.000538	CcSEcCtD
Ranitidine—Nausea—Conjugated Estrogens—prostate cancer	6.22e-05	0.000536	CcSEcCtD
Ranitidine—Urticaria—Mitoxantrone—prostate cancer	6.2e-05	0.000535	CcSEcCtD
Ranitidine—Breast disorder—Doxorubicin—prostate cancer	6.19e-05	0.000534	CcSEcCtD
Ranitidine—Hypersensitivity—Estradiol—prostate cancer	6.17e-05	0.000532	CcSEcCtD
Ranitidine—Abdominal pain—Mitoxantrone—prostate cancer	6.17e-05	0.000532	CcSEcCtD
Ranitidine—Body temperature increased—Mitoxantrone—prostate cancer	6.17e-05	0.000532	CcSEcCtD
Ranitidine—Anaemia—Docetaxel—prostate cancer	6.11e-05	0.000527	CcSEcCtD
Ranitidine—Pancytopenia—Epirubicin—prostate cancer	6.08e-05	0.000524	CcSEcCtD
Ranitidine—Hypotension—Etoposide—prostate cancer	6.07e-05	0.000523	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Doxorubicin—prostate cancer	6.04e-05	0.000521	CcSEcCtD
Ranitidine—Vision blurred—Capecitabine—prostate cancer	6.03e-05	0.00052	CcSEcCtD
Ranitidine—Neutropenia—Epirubicin—prostate cancer	5.98e-05	0.000516	CcSEcCtD
Ranitidine—Ill-defined disorder—Capecitabine—prostate cancer	5.94e-05	0.000512	CcSEcCtD
Ranitidine—Pruritus—Estradiol—prostate cancer	5.93e-05	0.000511	CcSEcCtD
Ranitidine—Dysphagia—Doxorubicin—prostate cancer	5.92e-05	0.000511	CcSEcCtD
Ranitidine—Leukopenia—Docetaxel—prostate cancer	5.92e-05	0.00051	CcSEcCtD
Ranitidine—Anaemia—Capecitabine—prostate cancer	5.92e-05	0.00051	CcSEcCtD
Ranitidine—Eosinophilia—Doxorubicin—prostate cancer	5.86e-05	0.000506	CcSEcCtD
Ranitidine—Arrhythmia—Prednisone—prostate cancer	5.85e-05	0.000505	CcSEcCtD
Ranitidine—Photosensitivity reaction—Epirubicin—prostate cancer	5.84e-05	0.000504	CcSEcCtD
Ranitidine—Pancreatitis—Doxorubicin—prostate cancer	5.81e-05	0.000501	CcSEcCtD
Ranitidine—Weight decreased—Epirubicin—prostate cancer	5.79e-05	0.000499	CcSEcCtD
Ranitidine—Dyspnoea—Etoposide—prostate cancer	5.79e-05	0.000499	CcSEcCtD
Ranitidine—Alopecia—Prednisone—prostate cancer	5.79e-05	0.000499	CcSEcCtD
Ranitidine—Malaise—Capecitabine—prostate cancer	5.77e-05	0.000498	CcSEcCtD
Ranitidine—Somnolence—Etoposide—prostate cancer	5.77e-05	0.000498	CcSEcCtD
Ranitidine—Angina pectoris—Doxorubicin—prostate cancer	5.77e-05	0.000498	CcSEcCtD
Ranitidine—Vertigo—Capecitabine—prostate cancer	5.75e-05	0.000496	CcSEcCtD
Ranitidine—Hypersensitivity—Mitoxantrone—prostate cancer	5.75e-05	0.000496	CcSEcCtD
Ranitidine—Pneumonia—Epirubicin—prostate cancer	5.74e-05	0.000495	CcSEcCtD
Ranitidine—Diarrhoea—Estradiol—prostate cancer	5.73e-05	0.000494	CcSEcCtD
Ranitidine—Leukopenia—Capecitabine—prostate cancer	5.73e-05	0.000494	CcSEcCtD
Ranitidine—Erythema—Prednisone—prostate cancer	5.7e-05	0.000492	CcSEcCtD
Ranitidine—Myalgia—Docetaxel—prostate cancer	5.63e-05	0.000486	CcSEcCtD
Ranitidine—Arthralgia—Docetaxel—prostate cancer	5.63e-05	0.000486	CcSEcCtD
Ranitidine—Chest pain—Docetaxel—prostate cancer	5.63e-05	0.000486	CcSEcCtD
Ranitidine—Pancytopenia—Doxorubicin—prostate cancer	5.62e-05	0.000485	CcSEcCtD
Ranitidine—Jaundice—Epirubicin—prostate cancer	5.56e-05	0.00048	CcSEcCtD
Ranitidine—Pain—Etoposide—prostate cancer	5.55e-05	0.000479	CcSEcCtD
Ranitidine—Constipation—Etoposide—prostate cancer	5.55e-05	0.000479	CcSEcCtD
Ranitidine—Dizziness—Estradiol—prostate cancer	5.54e-05	0.000478	CcSEcCtD
Ranitidine—Neutropenia—Doxorubicin—prostate cancer	5.54e-05	0.000478	CcSEcCtD
Ranitidine—Sweating—Epirubicin—prostate cancer	5.47e-05	0.000472	CcSEcCtD
Ranitidine—Myalgia—Capecitabine—prostate cancer	5.45e-05	0.00047	CcSEcCtD
Ranitidine—Arthralgia—Capecitabine—prostate cancer	5.45e-05	0.00047	CcSEcCtD
Ranitidine—Chest pain—Capecitabine—prostate cancer	5.45e-05	0.00047	CcSEcCtD
Ranitidine—Confusional state—Docetaxel—prostate cancer	5.44e-05	0.000469	CcSEcCtD
Ranitidine—Photosensitivity reaction—Doxorubicin—prostate cancer	5.41e-05	0.000466	CcSEcCtD
Ranitidine—Anaphylactic shock—Docetaxel—prostate cancer	5.4e-05	0.000465	CcSEcCtD
Ranitidine—Discomfort—Capecitabine—prostate cancer	5.38e-05	0.000464	CcSEcCtD
Ranitidine—Vision blurred—Prednisone—prostate cancer	5.37e-05	0.000464	CcSEcCtD
Ranitidine—Weight decreased—Doxorubicin—prostate cancer	5.36e-05	0.000462	CcSEcCtD
Ranitidine—Feeling abnormal—Etoposide—prostate cancer	5.35e-05	0.000462	CcSEcCtD
Ranitidine—Diarrhoea—Mitoxantrone—prostate cancer	5.34e-05	0.000461	CcSEcCtD
Ranitidine—Vomiting—Estradiol—prostate cancer	5.33e-05	0.000459	CcSEcCtD
Ranitidine—Agranulocytosis—Epirubicin—prostate cancer	5.33e-05	0.000459	CcSEcCtD
Ranitidine—Pneumonia—Doxorubicin—prostate cancer	5.31e-05	0.000458	CcSEcCtD
Ranitidine—Ill-defined disorder—Prednisone—prostate cancer	5.29e-05	0.000456	CcSEcCtD
Ranitidine—Thrombocytopenia—Docetaxel—prostate cancer	5.28e-05	0.000456	CcSEcCtD
Ranitidine—Rash—Estradiol—prostate cancer	5.28e-05	0.000456	CcSEcCtD
Ranitidine—Dermatitis—Estradiol—prostate cancer	5.28e-05	0.000455	CcSEcCtD
Ranitidine—Anaemia—Prednisone—prostate cancer	5.27e-05	0.000455	CcSEcCtD
Ranitidine—Confusional state—Capecitabine—prostate cancer	5.27e-05	0.000454	CcSEcCtD
Ranitidine—Tachycardia—Docetaxel—prostate cancer	5.27e-05	0.000454	CcSEcCtD
Ranitidine—Headache—Estradiol—prostate cancer	5.25e-05	0.000453	CcSEcCtD
Ranitidine—Agitation—Prednisone—prostate cancer	5.24e-05	0.000452	CcSEcCtD
Ranitidine—Bradycardia—Epirubicin—prostate cancer	5.21e-05	0.00045	CcSEcCtD
Ranitidine—Angioedema—Prednisone—prostate cancer	5.21e-05	0.000449	CcSEcCtD
Ranitidine—Urticaria—Etoposide—prostate cancer	5.16e-05	0.000445	CcSEcCtD
Ranitidine—Jaundice—Doxorubicin—prostate cancer	5.15e-05	0.000444	CcSEcCtD
Ranitidine—Malaise—Prednisone—prostate cancer	5.14e-05	0.000444	CcSEcCtD
Ranitidine—Abdominal pain—Etoposide—prostate cancer	5.13e-05	0.000443	CcSEcCtD
Ranitidine—Body temperature increased—Etoposide—prostate cancer	5.13e-05	0.000443	CcSEcCtD
Ranitidine—Vertigo—Prednisone—prostate cancer	5.12e-05	0.000442	CcSEcCtD
Ranitidine—Hepatitis—Epirubicin—prostate cancer	5.12e-05	0.000442	CcSEcCtD
Ranitidine—Thrombocytopenia—Capecitabine—prostate cancer	5.11e-05	0.000441	CcSEcCtD
Ranitidine—Tachycardia—Capecitabine—prostate cancer	5.1e-05	0.00044	CcSEcCtD
Ranitidine—Sweating—Doxorubicin—prostate cancer	5.06e-05	0.000437	CcSEcCtD
Ranitidine—Hyperhidrosis—Capecitabine—prostate cancer	5.05e-05	0.000436	CcSEcCtD
Ranitidine—Hypotension—Docetaxel—prostate cancer	5.04e-05	0.000435	CcSEcCtD
Ranitidine—Nausea—Estradiol—prostate cancer	4.98e-05	0.000429	CcSEcCtD
Ranitidine—Vomiting—Mitoxantrone—prostate cancer	4.96e-05	0.000428	CcSEcCtD
Ranitidine—Agranulocytosis—Doxorubicin—prostate cancer	4.93e-05	0.000425	CcSEcCtD
Ranitidine—Rash—Mitoxantrone—prostate cancer	4.92e-05	0.000425	CcSEcCtD
Ranitidine—Dermatitis—Mitoxantrone—prostate cancer	4.92e-05	0.000424	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Docetaxel—prostate cancer	4.92e-05	0.000424	CcSEcCtD
Ranitidine—Headache—Mitoxantrone—prostate cancer	4.89e-05	0.000422	CcSEcCtD
Ranitidine—Hypotension—Capecitabine—prostate cancer	4.88e-05	0.000421	CcSEcCtD
Ranitidine—Insomnia—Docetaxel—prostate cancer	4.88e-05	0.000421	CcSEcCtD
Ranitidine—Arthralgia—Prednisone—prostate cancer	4.85e-05	0.000419	CcSEcCtD
Ranitidine—Myalgia—Prednisone—prostate cancer	4.85e-05	0.000419	CcSEcCtD
Ranitidine—Erythema multiforme—Epirubicin—prostate cancer	4.84e-05	0.000418	CcSEcCtD
Ranitidine—Bradycardia—Doxorubicin—prostate cancer	4.83e-05	0.000416	CcSEcCtD
Ranitidine—Dyspnoea—Docetaxel—prostate cancer	4.81e-05	0.000415	CcSEcCtD
Ranitidine—Somnolence—Docetaxel—prostate cancer	4.8e-05	0.000414	CcSEcCtD
Ranitidine—Discomfort—Prednisone—prostate cancer	4.8e-05	0.000414	CcSEcCtD
Ranitidine—Hypersensitivity—Etoposide—prostate cancer	4.78e-05	0.000413	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Capecitabine—prostate cancer	4.76e-05	0.000411	CcSEcCtD
Ranitidine—Hepatitis—Doxorubicin—prostate cancer	4.74e-05	0.000409	CcSEcCtD
Ranitidine—Insomnia—Capecitabine—prostate cancer	4.72e-05	0.000408	CcSEcCtD
Ranitidine—Dyspnoea—Capecitabine—prostate cancer	4.66e-05	0.000402	CcSEcCtD
Ranitidine—Anaphylactic shock—Prednisone—prostate cancer	4.65e-05	0.000401	CcSEcCtD
Ranitidine—Nausea—Mitoxantrone—prostate cancer	4.64e-05	0.0004	CcSEcCtD
Ranitidine—Pain—Docetaxel—prostate cancer	4.61e-05	0.000398	CcSEcCtD
Ranitidine—Constipation—Docetaxel—prostate cancer	4.61e-05	0.000398	CcSEcCtD
Ranitidine—Pruritus—Etoposide—prostate cancer	4.59e-05	0.000396	CcSEcCtD
Ranitidine—Arrhythmia—Epirubicin—prostate cancer	4.58e-05	0.000395	CcSEcCtD
Ranitidine—Tachycardia—Prednisone—prostate cancer	4.54e-05	0.000392	CcSEcCtD
Ranitidine—Alopecia—Epirubicin—prostate cancer	4.53e-05	0.00039	CcSEcCtD
Ranitidine—Hyperhidrosis—Prednisone—prostate cancer	4.5e-05	0.000388	CcSEcCtD
Ranitidine—Erythema multiforme—Doxorubicin—prostate cancer	4.48e-05	0.000387	CcSEcCtD
Ranitidine—Constipation—Capecitabine—prostate cancer	4.47e-05	0.000385	CcSEcCtD
Ranitidine—Pain—Capecitabine—prostate cancer	4.47e-05	0.000385	CcSEcCtD
Ranitidine—Erythema—Epirubicin—prostate cancer	4.46e-05	0.000385	CcSEcCtD
Ranitidine—Feeling abnormal—Docetaxel—prostate cancer	4.45e-05	0.000384	CcSEcCtD
Ranitidine—Diarrhoea—Etoposide—prostate cancer	4.44e-05	0.000383	CcSEcCtD
Ranitidine—Feeling abnormal—Capecitabine—prostate cancer	4.3e-05	0.000371	CcSEcCtD
Ranitidine—Dizziness—Etoposide—prostate cancer	4.29e-05	0.00037	CcSEcCtD
Ranitidine—Body temperature increased—Docetaxel—prostate cancer	4.27e-05	0.000368	CcSEcCtD
Ranitidine—Abdominal pain—Docetaxel—prostate cancer	4.27e-05	0.000368	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Prednisone—prostate cancer	4.24e-05	0.000366	CcSEcCtD
Ranitidine—Arrhythmia—Doxorubicin—prostate cancer	4.23e-05	0.000365	CcSEcCtD
Ranitidine—Insomnia—Prednisone—prostate cancer	4.21e-05	0.000363	CcSEcCtD
Ranitidine—Vision blurred—Epirubicin—prostate cancer	4.2e-05	0.000363	CcSEcCtD
Ranitidine—Alopecia—Doxorubicin—prostate cancer	4.19e-05	0.000361	CcSEcCtD
Ranitidine—Urticaria—Capecitabine—prostate cancer	4.15e-05	0.000358	CcSEcCtD
Ranitidine—Ill-defined disorder—Epirubicin—prostate cancer	4.14e-05	0.000357	CcSEcCtD
Ranitidine—Abdominal pain—Capecitabine—prostate cancer	4.13e-05	0.000356	CcSEcCtD
Ranitidine—Body temperature increased—Capecitabine—prostate cancer	4.13e-05	0.000356	CcSEcCtD
Ranitidine—Vomiting—Etoposide—prostate cancer	4.13e-05	0.000356	CcSEcCtD
Ranitidine—Erythema—Doxorubicin—prostate cancer	4.13e-05	0.000356	CcSEcCtD
Ranitidine—Anaemia—Epirubicin—prostate cancer	4.12e-05	0.000356	CcSEcCtD
Ranitidine—Agitation—Epirubicin—prostate cancer	4.1e-05	0.000354	CcSEcCtD
Ranitidine—Rash—Etoposide—prostate cancer	4.09e-05	0.000353	CcSEcCtD
Ranitidine—Dermatitis—Etoposide—prostate cancer	4.09e-05	0.000353	CcSEcCtD
Ranitidine—Headache—Etoposide—prostate cancer	4.07e-05	0.000351	CcSEcCtD
Ranitidine—Malaise—Epirubicin—prostate cancer	4.02e-05	0.000347	CcSEcCtD
Ranitidine—Vertigo—Epirubicin—prostate cancer	4.01e-05	0.000346	CcSEcCtD
Ranitidine—Leukopenia—Epirubicin—prostate cancer	3.99e-05	0.000344	CcSEcCtD
Ranitidine—Constipation—Prednisone—prostate cancer	3.98e-05	0.000343	CcSEcCtD
Ranitidine—Hypersensitivity—Docetaxel—prostate cancer	3.98e-05	0.000343	CcSEcCtD
Ranitidine—Vision blurred—Doxorubicin—prostate cancer	3.89e-05	0.000335	CcSEcCtD
Ranitidine—Nausea—Etoposide—prostate cancer	3.86e-05	0.000333	CcSEcCtD
Ranitidine—Hypersensitivity—Capecitabine—prostate cancer	3.85e-05	0.000332	CcSEcCtD
Ranitidine—Feeling abnormal—Prednisone—prostate cancer	3.83e-05	0.000331	CcSEcCtD
Ranitidine—Ill-defined disorder—Doxorubicin—prostate cancer	3.83e-05	0.00033	CcSEcCtD
Ranitidine—Pruritus—Docetaxel—prostate cancer	3.82e-05	0.000329	CcSEcCtD
Ranitidine—Anaemia—Doxorubicin—prostate cancer	3.81e-05	0.000329	CcSEcCtD
Ranitidine—Arthralgia—Epirubicin—prostate cancer	3.8e-05	0.000327	CcSEcCtD
Ranitidine—Chest pain—Epirubicin—prostate cancer	3.8e-05	0.000327	CcSEcCtD
Ranitidine—Myalgia—Epirubicin—prostate cancer	3.8e-05	0.000327	CcSEcCtD
Ranitidine—Agitation—Doxorubicin—prostate cancer	3.79e-05	0.000327	CcSEcCtD
Ranitidine—Discomfort—Epirubicin—prostate cancer	3.75e-05	0.000324	CcSEcCtD
Ranitidine—Malaise—Doxorubicin—prostate cancer	3.72e-05	0.000321	CcSEcCtD
Ranitidine—Vertigo—Doxorubicin—prostate cancer	3.71e-05	0.00032	CcSEcCtD
Ranitidine—Urticaria—Prednisone—prostate cancer	3.7e-05	0.000319	CcSEcCtD
Ranitidine—Pruritus—Capecitabine—prostate cancer	3.7e-05	0.000319	CcSEcCtD
Ranitidine—Leukopenia—Doxorubicin—prostate cancer	3.69e-05	0.000319	CcSEcCtD
Ranitidine—Diarrhoea—Docetaxel—prostate cancer	3.69e-05	0.000318	CcSEcCtD
Ranitidine—Body temperature increased—Prednisone—prostate cancer	3.68e-05	0.000317	CcSEcCtD
Ranitidine—Abdominal pain—Prednisone—prostate cancer	3.68e-05	0.000317	CcSEcCtD
Ranitidine—Confusional state—Epirubicin—prostate cancer	3.67e-05	0.000317	CcSEcCtD
Ranitidine—Anaphylactic shock—Epirubicin—prostate cancer	3.64e-05	0.000314	CcSEcCtD
Ranitidine—Diarrhoea—Capecitabine—prostate cancer	3.57e-05	0.000308	CcSEcCtD
Ranitidine—Dizziness—Docetaxel—prostate cancer	3.57e-05	0.000308	CcSEcCtD
Ranitidine—Thrombocytopenia—Epirubicin—prostate cancer	3.56e-05	0.000307	CcSEcCtD
Ranitidine—Tachycardia—Epirubicin—prostate cancer	3.55e-05	0.000306	CcSEcCtD
Ranitidine—Hyperhidrosis—Epirubicin—prostate cancer	3.52e-05	0.000303	CcSEcCtD
Ranitidine—Myalgia—Doxorubicin—prostate cancer	3.51e-05	0.000303	CcSEcCtD
Ranitidine—Arthralgia—Doxorubicin—prostate cancer	3.51e-05	0.000303	CcSEcCtD
Ranitidine—Chest pain—Doxorubicin—prostate cancer	3.51e-05	0.000303	CcSEcCtD
Ranitidine—Discomfort—Doxorubicin—prostate cancer	3.47e-05	0.000299	CcSEcCtD
Ranitidine—Dizziness—Capecitabine—prostate cancer	3.45e-05	0.000298	CcSEcCtD
Ranitidine—Vomiting—Docetaxel—prostate cancer	3.43e-05	0.000296	CcSEcCtD
Ranitidine—Hypersensitivity—Prednisone—prostate cancer	3.43e-05	0.000296	CcSEcCtD
Ranitidine—Rash—Docetaxel—prostate cancer	3.4e-05	0.000293	CcSEcCtD
Ranitidine—Hypotension—Epirubicin—prostate cancer	3.4e-05	0.000293	CcSEcCtD
Ranitidine—Dermatitis—Docetaxel—prostate cancer	3.4e-05	0.000293	CcSEcCtD
Ranitidine—Confusional state—Doxorubicin—prostate cancer	3.4e-05	0.000293	CcSEcCtD
Ranitidine—Headache—Docetaxel—prostate cancer	3.38e-05	0.000292	CcSEcCtD
Ranitidine—Anaphylactic shock—Doxorubicin—prostate cancer	3.37e-05	0.00029	CcSEcCtD
Ranitidine—Vomiting—Capecitabine—prostate cancer	3.32e-05	0.000287	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Epirubicin—prostate cancer	3.32e-05	0.000286	CcSEcCtD
Ranitidine—Thrombocytopenia—Doxorubicin—prostate cancer	3.3e-05	0.000284	CcSEcCtD
Ranitidine—Rash—Capecitabine—prostate cancer	3.29e-05	0.000284	CcSEcCtD
Ranitidine—Pruritus—Prednisone—prostate cancer	3.29e-05	0.000284	CcSEcCtD
Ranitidine—Insomnia—Epirubicin—prostate cancer	3.29e-05	0.000284	CcSEcCtD
Ranitidine—Dermatitis—Capecitabine—prostate cancer	3.29e-05	0.000284	CcSEcCtD
Ranitidine—Tachycardia—Doxorubicin—prostate cancer	3.29e-05	0.000284	CcSEcCtD
Ranitidine—Headache—Capecitabine—prostate cancer	3.27e-05	0.000282	CcSEcCtD
Ranitidine—Hyperhidrosis—Doxorubicin—prostate cancer	3.26e-05	0.000281	CcSEcCtD
Ranitidine—Dyspnoea—Epirubicin—prostate cancer	3.24e-05	0.00028	CcSEcCtD
Ranitidine—Somnolence—Epirubicin—prostate cancer	3.24e-05	0.000279	CcSEcCtD
Ranitidine—Nausea—Docetaxel—prostate cancer	3.2e-05	0.000276	CcSEcCtD
Ranitidine—Diarrhoea—Prednisone—prostate cancer	3.18e-05	0.000275	CcSEcCtD
Ranitidine—Hypotension—Doxorubicin—prostate cancer	3.15e-05	0.000271	CcSEcCtD
Ranitidine—Pain—Epirubicin—prostate cancer	3.11e-05	0.000268	CcSEcCtD
Ranitidine—Constipation—Epirubicin—prostate cancer	3.11e-05	0.000268	CcSEcCtD
Ranitidine—Nausea—Capecitabine—prostate cancer	3.1e-05	0.000268	CcSEcCtD
Ranitidine—Dizziness—Prednisone—prostate cancer	3.08e-05	0.000265	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Doxorubicin—prostate cancer	3.07e-05	0.000265	CcSEcCtD
Ranitidine—Insomnia—Doxorubicin—prostate cancer	3.05e-05	0.000263	CcSEcCtD
Ranitidine—Dyspnoea—Doxorubicin—prostate cancer	3e-05	0.000259	CcSEcCtD
Ranitidine—Feeling abnormal—Epirubicin—prostate cancer	3e-05	0.000259	CcSEcCtD
Ranitidine—Somnolence—Doxorubicin—prostate cancer	2.99e-05	0.000258	CcSEcCtD
Ranitidine—Vomiting—Prednisone—prostate cancer	2.96e-05	0.000255	CcSEcCtD
Ranitidine—Rash—Prednisone—prostate cancer	2.93e-05	0.000253	CcSEcCtD
Ranitidine—Dermatitis—Prednisone—prostate cancer	2.93e-05	0.000253	CcSEcCtD
Ranitidine—Headache—Prednisone—prostate cancer	2.92e-05	0.000251	CcSEcCtD
Ranitidine—Urticaria—Epirubicin—prostate cancer	2.89e-05	0.000249	CcSEcCtD
Ranitidine—Pain—Doxorubicin—prostate cancer	2.88e-05	0.000248	CcSEcCtD
Ranitidine—Constipation—Doxorubicin—prostate cancer	2.88e-05	0.000248	CcSEcCtD
Ranitidine—Abdominal pain—Epirubicin—prostate cancer	2.88e-05	0.000248	CcSEcCtD
Ranitidine—Body temperature increased—Epirubicin—prostate cancer	2.88e-05	0.000248	CcSEcCtD
Ranitidine—Feeling abnormal—Doxorubicin—prostate cancer	2.77e-05	0.000239	CcSEcCtD
Ranitidine—Nausea—Prednisone—prostate cancer	2.76e-05	0.000238	CcSEcCtD
Ranitidine—Hypersensitivity—Epirubicin—prostate cancer	2.68e-05	0.000231	CcSEcCtD
Ranitidine—Urticaria—Doxorubicin—prostate cancer	2.68e-05	0.000231	CcSEcCtD
Ranitidine—Abdominal pain—Doxorubicin—prostate cancer	2.66e-05	0.00023	CcSEcCtD
Ranitidine—Body temperature increased—Doxorubicin—prostate cancer	2.66e-05	0.00023	CcSEcCtD
Ranitidine—Pruritus—Epirubicin—prostate cancer	2.57e-05	0.000222	CcSEcCtD
Ranitidine—Diarrhoea—Epirubicin—prostate cancer	2.49e-05	0.000215	CcSEcCtD
Ranitidine—Hypersensitivity—Doxorubicin—prostate cancer	2.48e-05	0.000214	CcSEcCtD
Ranitidine—Dizziness—Epirubicin—prostate cancer	2.41e-05	0.000208	CcSEcCtD
Ranitidine—Pruritus—Doxorubicin—prostate cancer	2.38e-05	0.000206	CcSEcCtD
Ranitidine—Vomiting—Epirubicin—prostate cancer	2.31e-05	0.0002	CcSEcCtD
Ranitidine—Diarrhoea—Doxorubicin—prostate cancer	2.3e-05	0.000199	CcSEcCtD
Ranitidine—Rash—Epirubicin—prostate cancer	2.29e-05	0.000198	CcSEcCtD
Ranitidine—Dermatitis—Epirubicin—prostate cancer	2.29e-05	0.000198	CcSEcCtD
Ranitidine—Headache—Epirubicin—prostate cancer	2.28e-05	0.000197	CcSEcCtD
Ranitidine—Dizziness—Doxorubicin—prostate cancer	2.23e-05	0.000192	CcSEcCtD
Ranitidine—Nausea—Epirubicin—prostate cancer	2.16e-05	0.000186	CcSEcCtD
Ranitidine—Vomiting—Doxorubicin—prostate cancer	2.14e-05	0.000185	CcSEcCtD
Ranitidine—Rash—Doxorubicin—prostate cancer	2.12e-05	0.000183	CcSEcCtD
Ranitidine—Dermatitis—Doxorubicin—prostate cancer	2.12e-05	0.000183	CcSEcCtD
Ranitidine—Headache—Doxorubicin—prostate cancer	2.11e-05	0.000182	CcSEcCtD
Ranitidine—Nausea—Doxorubicin—prostate cancer	2e-05	0.000173	CcSEcCtD
Ranitidine—CYP3A5—Metabolism—TYMS—prostate cancer	3.11e-06	4.29e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MMP9—prostate cancer	3.11e-06	4.29e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NQO1—prostate cancer	3.1e-06	4.28e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CDKN1A—prostate cancer	3.1e-06	4.27e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NCOA2—prostate cancer	3.1e-06	4.27e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTEN—prostate cancer	3.09e-06	4.26e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.09e-06	4.26e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GSTM1—prostate cancer	3.08e-06	4.24e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP2E1—prostate cancer	3.06e-06	4.22e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TH—prostate cancer	3.06e-06	4.21e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.04e-06	4.19e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTA2—prostate cancer	3.04e-06	4.18e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NQO1—prostate cancer	3.03e-06	4.17e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP3A4—prostate cancer	3.03e-06	4.17e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—LPL—prostate cancer	3.02e-06	4.16e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—AKT1—prostate cancer	3.02e-06	4.16e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.01e-06	4.15e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—HPGDS—prostate cancer	3e-06	4.13e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SULT1A1—prostate cancer	3e-06	4.13e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ABCG5—prostate cancer	3e-06	4.13e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TH—prostate cancer	2.99e-06	4.11e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP2C19—prostate cancer	2.98e-06	4.11e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP1B1—prostate cancer	2.98e-06	4.1e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.96e-06	4.07e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP3A4—prostate cancer	2.95e-06	4.07e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EP300—prostate cancer	2.95e-06	4.06e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CG—prostate cancer	2.94e-06	4.05e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTA1—prostate cancer	2.93e-06	4.04e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.92e-06	4.02e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ACHE—prostate cancer	2.91e-06	4.01e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTT1—prostate cancer	2.91e-06	4.01e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP1B1—prostate cancer	2.9e-06	4e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.9e-06	3.99e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTO1—prostate cancer	2.9e-06	3.99e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NAT2—prostate cancer	2.9e-06	3.99e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ERCC2—prostate cancer	2.89e-06	3.99e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP2E1—prostate cancer	2.89e-06	3.98e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GGT1—prostate cancer	2.88e-06	3.97e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.88e-06	3.96e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SRC—prostate cancer	2.87e-06	3.95e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.86e-06	3.95e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NQO1—prostate cancer	2.85e-06	3.93e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NCOA1—prostate cancer	2.84e-06	3.91e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TH—prostate cancer	2.81e-06	3.88e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GGT1—prostate cancer	2.81e-06	3.88e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.8e-06	3.86e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.8e-06	3.85e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—VEGFA—prostate cancer	2.79e-06	3.85e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—INS—prostate cancer	2.78e-06	3.84e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP3A4—prostate cancer	2.78e-06	3.84e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PRKACB—prostate cancer	2.78e-06	3.83e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—LRP2—prostate cancer	2.78e-06	3.83e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PLCB2—prostate cancer	2.78e-06	3.83e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.78e-06	3.83e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NCOA1—prostate cancer	2.77e-06	3.82e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—prostate cancer	2.77e-06	3.81e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.75e-06	3.8e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP1B1—prostate cancer	2.74e-06	3.77e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP19A1—prostate cancer	2.73e-06	3.76e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—CREBBP—prostate cancer	2.73e-06	3.76e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—P4HB—prostate cancer	2.72e-06	3.75e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—MTHFR—prostate cancer	2.72e-06	3.75e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.72e-06	3.74e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—RXRA—prostate cancer	2.7e-06	3.72e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PPARA—prostate cancer	2.67e-06	3.68e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GGT1—prostate cancer	2.65e-06	3.65e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.65e-06	3.65e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—RXRA—prostate cancer	2.63e-06	3.63e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.63e-06	3.62e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOA2—prostate cancer	2.62e-06	3.62e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NCOA1—prostate cancer	2.61e-06	3.6e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—COMT—prostate cancer	2.6e-06	3.58e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTP1—prostate cancer	2.59e-06	3.57e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CD—prostate cancer	2.59e-06	3.56e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.58e-06	3.56e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP19A1—prostate cancer	2.57e-06	3.55e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MYC—prostate cancer	2.57e-06	3.54e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TGFB1—prostate cancer	2.56e-06	3.53e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ITPR1—prostate cancer	2.55e-06	3.51e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MED12—prostate cancer	2.54e-06	3.5e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—COMT—prostate cancer	2.54e-06	3.5e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTP1—prostate cancer	2.53e-06	3.48e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GNG5—prostate cancer	2.52e-06	3.47e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—EGFR—prostate cancer	2.51e-06	3.46e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CAV1—prostate cancer	2.51e-06	3.46e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.5e-06	3.45e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.5e-06	3.45e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ITPR1—prostate cancer	2.49e-06	3.43e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—RXRA—prostate cancer	2.48e-06	3.42e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.45e-06	3.37e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—NOS3—prostate cancer	2.44e-06	3.36e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOA3—prostate cancer	2.43e-06	3.34e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NQO1—prostate cancer	2.42e-06	3.33e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—TYMS—prostate cancer	2.41e-06	3.32e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—COMT—prostate cancer	2.39e-06	3.3e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TH—prostate cancer	2.38e-06	3.28e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTP1—prostate cancer	2.38e-06	3.28e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GSTM1—prostate cancer	2.38e-06	3.28e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—KRAS—prostate cancer	2.37e-06	3.27e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.37e-06	3.26e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.36e-06	3.25e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—TYMS—prostate cancer	2.35e-06	3.24e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.35e-06	3.23e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ITPR1—prostate cancer	2.34e-06	3.23e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—LPL—prostate cancer	2.33e-06	3.22e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GSTM1—prostate cancer	2.32e-06	3.2e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.32e-06	3.19e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—HPGDS—prostate cancer	2.32e-06	3.19e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.3e-06	3.17e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CG—prostate cancer	2.28e-06	3.15e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—LPL—prostate cancer	2.28e-06	3.14e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.25e-06	3.11e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CB—prostate cancer	2.25e-06	3.11e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTT1—prostate cancer	2.25e-06	3.09e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ACHE—prostate cancer	2.25e-06	3.09e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GGT1—prostate cancer	2.25e-06	3.09e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ERCC2—prostate cancer	2.24e-06	3.08e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS2—prostate cancer	2.23e-06	3.08e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.22e-06	3.06e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—TYMS—prostate cancer	2.21e-06	3.05e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NCOA1—prostate cancer	2.21e-06	3.05e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CYP1A1—prostate cancer	2.2e-06	3.03e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GSTM1—prostate cancer	2.19e-06	3.01e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ERCC2—prostate cancer	2.18e-06	3.01e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PIK3CA—prostate cancer	2.18e-06	3.01e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.18e-06	3e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—INS—prostate cancer	2.16e-06	2.98e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.16e-06	2.98e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PRKACB—prostate cancer	2.15e-06	2.96e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—LPL—prostate cancer	2.15e-06	2.96e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.13e-06	2.93e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—CREBBP—prostate cancer	2.12e-06	2.92e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TP53—prostate cancer	2.11e-06	2.91e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—RXRA—prostate cancer	2.1e-06	2.9e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—MTHFR—prostate cancer	2.1e-06	2.9e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CYP1A1—prostate cancer	2.07e-06	2.86e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PPARA—prostate cancer	2.06e-06	2.84e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ERCC2—prostate cancer	2.06e-06	2.83e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—MTHFR—prostate cancer	2.05e-06	2.83e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.05e-06	2.82e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—COMT—prostate cancer	2.03e-06	2.79e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOA2—prostate cancer	2.03e-06	2.79e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTP1—prostate cancer	2.02e-06	2.78e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PPARA—prostate cancer	2.01e-06	2.77e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.01e-06	2.77e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ITPR1—prostate cancer	1.98e-06	2.73e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.95e-06	2.69e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTEN—prostate cancer	1.95e-06	2.68e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CAV1—prostate cancer	1.94e-06	2.67e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—MTHFR—prostate cancer	1.93e-06	2.66e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL6—prostate cancer	1.93e-06	2.66e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.93e-06	2.66e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PPARA—prostate cancer	1.9e-06	2.61e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—NOS3—prostate cancer	1.9e-06	2.61e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CAV1—prostate cancer	1.89e-06	2.61e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.89e-06	2.6e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—TYMS—prostate cancer	1.87e-06	2.58e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NQO1—prostate cancer	1.87e-06	2.57e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—EP300—prostate cancer	1.86e-06	2.56e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GSTM1—prostate cancer	1.85e-06	2.55e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.85e-06	2.55e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TH—prostate cancer	1.84e-06	2.53e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—LPL—prostate cancer	1.82e-06	2.51e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.79e-06	2.47e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CAV1—prostate cancer	1.78e-06	2.46e-05	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—AKT1—prostate cancer	1.78e-06	2.46e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.77e-06	2.43e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.76e-06	2.42e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.75e-06	2.41e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ERCC2—prostate cancer	1.74e-06	2.4e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS2—prostate cancer	1.73e-06	2.39e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GGT1—prostate cancer	1.73e-06	2.39e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CG—prostate cancer	1.72e-06	2.38e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NCOA1—prostate cancer	1.71e-06	2.35e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.68e-06	2.32e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—INS—prostate cancer	1.67e-06	2.3e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MTHFR—prostate cancer	1.64e-06	2.26e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—CREBBP—prostate cancer	1.64e-06	2.26e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—INS—prostate cancer	1.63e-06	2.25e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.62e-06	2.24e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—RXRA—prostate cancer	1.62e-06	2.24e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PPARA—prostate cancer	1.61e-06	2.21e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—CREBBP—prostate cancer	1.6e-06	2.2e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—COMT—prostate cancer	1.56e-06	2.15e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTP1—prostate cancer	1.56e-06	2.14e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.55e-06	2.14e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—INS—prostate cancer	1.54e-06	2.12e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ITPR1—prostate cancer	1.53e-06	2.11e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CD—prostate cancer	1.52e-06	2.09e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTEN—prostate cancer	1.51e-06	2.08e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CAV1—prostate cancer	1.51e-06	2.08e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—CREBBP—prostate cancer	1.51e-06	2.08e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—NOS3—prostate cancer	1.47e-06	2.02e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—TYMS—prostate cancer	1.45e-06	1.99e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.44e-06	1.99e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—EP300—prostate cancer	1.44e-06	1.99e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—NOS3—prostate cancer	1.43e-06	1.97e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GSTM1—prostate cancer	1.43e-06	1.97e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.43e-06	1.97e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—LPL—prostate cancer	1.4e-06	1.93e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.38e-06	1.9e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PIK3CA—prostate cancer	1.37e-06	1.89e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.36e-06	1.87e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.35e-06	1.86e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—NOS3—prostate cancer	1.35e-06	1.86e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ERCC2—prostate cancer	1.34e-06	1.85e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS2—prostate cancer	1.34e-06	1.85e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.32e-06	1.82e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS2—prostate cancer	1.31e-06	1.8e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—INS—prostate cancer	1.3e-06	1.8e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.28e-06	1.76e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.26e-06	1.74e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.24e-06	1.72e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PPARA—prostate cancer	1.24e-06	1.71e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.23e-06	1.7e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.21e-06	1.67e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTEN—prostate cancer	1.17e-06	1.61e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CAV1—prostate cancer	1.17e-06	1.61e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—NOS3—prostate cancer	1.14e-06	1.57e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTEN—prostate cancer	1.14e-06	1.57e-05	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—AKT1—prostate cancer	1.12e-06	1.55e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—EP300—prostate cancer	1.12e-06	1.54e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—EP300—prostate cancer	1.09e-06	1.5e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTEN—prostate cancer	1.08e-06	1.48e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.07e-06	1.47e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.06e-06	1.46e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.05e-06	1.45e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.04e-06	1.44e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—EP300—prostate cancer	1.03e-06	1.41e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—INS—prostate cancer	1.01e-06	1.39e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—CREBBP—prostate cancer	9.85e-07	1.36e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.34e-07	1.29e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTEN—prostate cancer	9.11e-07	1.26e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—NOS3—prostate cancer	8.82e-07	1.21e-05	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—AKT1—prostate cancer	8.72e-07	1.2e-05	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—EP300—prostate cancer	8.69e-07	1.2e-05	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PIK3CA—prostate cancer	8.25e-07	1.14e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.14e-07	1.12e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS2—prostate cancer	8.06e-07	1.11e-05	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PIK3CA—prostate cancer	8.05e-07	1.11e-05	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PIK3CA—prostate cancer	7.59e-07	1.05e-05	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTEN—prostate cancer	7.03e-07	9.69e-06	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—AKT1—prostate cancer	6.74e-07	9.29e-06	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—EP300—prostate cancer	6.71e-07	9.24e-06	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—AKT1—prostate cancer	6.58e-07	9.06e-06	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.43e-07	8.86e-06	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—AKT1—prostate cancer	6.2e-07	8.54e-06	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—AKT1—prostate cancer	5.25e-07	7.24e-06	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PIK3CA—prostate cancer	4.96e-07	6.84e-06	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—AKT1—prostate cancer	4.05e-07	5.58e-06	CbGpPWpGaD
